A Light-Sensitive Surfactant: Photodegradation Alters Drug Formulation Stability
A study published in *Molecular Pharmaceutics* investigates the photostability of polysorbate 80 (PS80), a common surfactant and excipient used in biopharmaceutical formulations. The research examines how surface activity changes after the surfactant is irradiated with light in a citrate buffer solution containing iron and disulfide compounds. This process simulates potential degradation pathways that could occur during manufacturing, storage, or handling of injectable drug products. The findings highlight a specific vulnerability where light exposure, in the presence of certain buffer components, can alter the surfactant’s critical micelle concentration and surface tension properties. This degradation could potentially compromise the stability of protein-based therapeutics and monoclonal antibodies that rely on PS80 to prevent aggregation and maintain solubility, directly impacting drug delivery systems and final product efficacy.
Why it might matter to you: For professionals focused on pharmacokinetics and drug development, this research underscores a non-obvious factor in therapeutic drug monitoring and product shelf-life. Understanding excipient degradation pathways is crucial for predicting adverse drug reactions and ensuring consistent bioavailability, especially for sensitive biopharmaceuticals. It prompts a re-evaluation of formulation protocols and storage conditions to mitigate risks of potency loss or increased immunogenicity in final products.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.